APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy
Preprint
Abstract
Background: African polymorphisms in the gene for Apolipoprotein L1 ( APOL1 ) confer a survival advantage against lethal trypanosomiasis but also an increased risk for several chronic kidney diseases (CKD) including HIV-associated nephropathy (HIVAN). APOL1 is expressed in renal cells, however, the pathogenic events that lead to renal cell damage and kidney disease are not fully understood. Methods: The podocyte function of APOL1-G0 versus APOL1-G2 in the setting of a known disease stressor was assessed using transgenic mouse models. Survival, renal pathology and function, and podocyte density were assessed in an intercross of a mouse model of HIVAN (Tg26) with two mouse models that express either APOL1-G0 or APOL1-G2 in podocytes. Results: Mice that expressed HIV genes developed heavy proteinuria and glomerulosclerosis, and had significant losses in podocyte numbers and reductions in podocyte densities. Mice that co-expressed APOL1-G0 and HIV had preserved podocyte numbers and densities, with fewer morphologic manifestations typical of HIVAN pathology. Podocyte losses and pathology in mice co-expressing APOL1-G2 and HIV were not significantly different from mice expressing only HIV. Podocyte hypertrophy, a known compensatory event to stress, was increased in the mice co-expressing HIV and APOL1-G0 , but absent in the mice co-expressing HIV and APOL1-G2 . Mortality and renal function tests were not significantly different between groups. Conclusions: APOL1-G0 expressed in podocytes may have a protective function against podocyte loss or injury when exposed to an environmental stressor. This function appears to be absent with APOL1-G2 expression, suggesting APOL1-G2 is a loss-of-function variant.Keywords
All Related Versions
- Published version: PLOS ONE, 14 (10), e0224408.
This publication has 35 references indexed in Scilit:
- APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated NephropathyJournal of the American Society of Nephrology, 2011
- APOL1 Localization in Normal Kidney and Nondiabetic Kidney DiseaseJournal of the American Society of Nephrology, 2011
- Identification of the Nephropathy-Susceptibility Locus HIVAN4Journal of the American Society of Nephrology, 2011
- The APOL1 Gene and Allograft Survival after Kidney TransplantationAmerican Journal of Transplantation, 2011
- Association of Trypanolytic ApoL1 Variants with Kidney Disease in African AmericansScience, 2010
- Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 geneHuman Genetics, 2010
- HIV-1 Genes vpr and nef Synergistically Damage Podocytes, Leading to GlomerulosclerosisJournal of the American Society of Nephrology, 2006
- Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathyKidney International, 2005
- Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression.Journal of Clinical Investigation, 1997
- Viral DNA in microdissected renal biopsy tissue from HIV infected patients with nephrotic syndromeKidney International, 1993